Usefulness of interferon-γ release assays in the diagnosis of erythema induratum

Archives of Dermatology

Volumn 147, Issue 8, 2011, Pages 949-952

  Vera Kellet, Cristián ^a,c   Peters, Laurenna ^b   Elwood, Kevin ^b   Dutz, Jan P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; ISONIAZID; PYRIDOXINE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIUM CULTURE; BCG VACCINATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; INTERFERON GAMMA RELEASE ASSAY; LOWER LEG; MALE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN NODULE; SKIN TUBERCULOSIS; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; ERYTHEMA INDURATUM; FEMALE; HUMANS; INTERFERON-GAMMA; MIDDLE AGED;

EID: 80051677475     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.183     Document Type: Article

References (21)

1. Ollert MW, Thomas P, Korting HC, Schraut W, Braun-Falco O. Erythema induratum of Bazin: evidence of T-lymphocyte hyperresponsiveness to purified protein derivative of tuberculin: report of two cases and treatment. Arch Dermatol. 1993;129(4):469-473. (Pubitemid 23118244)
2. Ho CK, Ho MH, Chong LY. Cutaneous tuberculosis in Hong Kong: an update. Hong Kong Med J. 2006;12(4):272-277. (Pubitemid 44285140)
3. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection: United States, 2010. MMWR Recomm Rep. 2010;59(RR-5):1-25.
4. Mascaró JM Jr, Baselga E. Erythema induratum of Bazin. Dermatol Clin. 2008;26 (4):439-445, v.
5. Montgomery H, Leary PA, Barker NW. Nodular vascular diseases of the legs: erythema induratum and allied conditions. JAMA. 1945;128(5):335-341.
6. Lighter J, Tse DB, Li Y, Borkowsky W. Erythema induratum of Bazin in a child: evidence for a cell-mediated hyper-response to Mycobacterium tuberculosis. Pediatr Infect Dis J. 2009;28(4):326-328.
7. Hsiao P-F, Tzen C-Y, Chen H-C, Su H-Y. Polymerase chain reaction based detection of Mycobacterium tuberculosis in tissues showing granulomatous inflammation without demonstrable acid-fast bacilli. Int J Dermatol. 2003;42(4):281-286. (Pubitemid 36553223)
8. Tan SH, Tan BH, Goh CL, et al. Detection of Mycobacterium tuberculosis DNA using polymerase chain reaction in cutaneous tuberculosis and tuberculids. Int J Dermatol. 1999;38(2):122-127. (Pubitemid 29136864)
9. Vieites B, Suárez-Peñaranda JM, Pérez Del Molino ML, et al. Recovery of Mycobacterium tuberculosis DNA in biopsies of erythema induratum: results in a series of patients using an improved polymerase chain reaction technique. Br J Dermatol. 2005;152(6):1394-1396. (Pubitemid 40933469)
10. Quirós E, Bettinardi A, Quirós A, Piédrola G, Maroto MC. Detection of mycobacterial DNA in papulonecrotic tuberculid lesions by polymerase chain reaction. J Clin Lab Anal. 2000;14(4):133-135. (Pubitemid 30480175)
11. Rowland K, Guthmann R, Jamieson B, Malloy D. Clinical inquiries: how should we manage a patient with a positive PPD and prior BCG vaccination? J Fam Pract. 2006;55(8):718-720. (Pubitemid 44699420)
12. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of bacille Calmette Guérin vaccination on tuberculin skin test measurements [published correction appears in Thorax. 2003;58(2):188]. Thorax. 2002; 57(9):804-809. (Pubitemid 34984980)
13. Kobashi Y, Mouri K, Yagi S, et al. Clinical evaluation for diagnosing active TB disease and transitional change of two commercial blood tests. Scand J Infect Dis. 2008;40(8):629-634.
14. Adams LV, Waddell RD, Von Reyn CF. T-SPOT.TB Test® results in adults with Mycobacterium avium complex pulmonary disease. Scand J Infect Dis. 2008; 40(3):196-203. (Pubitemid 351260426)
15. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research [published correction appears in Ann Intern Med. 2007;146(9):688]. Ann Intern Med. 2007;146(5):340-354. (Pubitemid 351650594)
16. Kobashi Y, Mouri K, Yagi S, et al. Clinical evaluation of the QuantiFERON®-TB Gold test in patients with non-tuberculous mycobacterial disease. Int J Tuberc Lung Dis. 2009;13(11):1422-1426.
17. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008; 149(3):177-184.
18. Bosshard V, Roux-Lombard P, Perneger T, et al. Do results of the T-SPOT.TB interferon-γ release assay change after treatment of tuberculosis? Respir Med. 2009;103(1):30-34.
19. Lee SH, Lew WJ, Kim HJ, et al. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak. Respir Med. 2010;104(3):448- 453.
20. Ribeiro S, Dooley K, Hackman J, et al. T-SPOT.TB responses during treatment of pulmonary tuberculosis.BMCInfect Dis. 2009;9(1):e23. doi:10.1186/1471-2334-9-23.
21. Chee CBE, Gan SH, KhinMar KW, et al. Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis. J Clin Microbiol. 2008;46(6):1935-1940. (Pubitemid 351831823)